MDA-9/Syntenin Control

Journal of Cellular Physiology

Volumn 231, Issue 3, 2016, Pages 545-550

  Philley, Julie V ^a   Kannan, Anbarasu ^b   Dasgupta, Santanu ^b  

^a Baylor UT Houston Center for AIDS Research   (United States)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARANASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SOMATOMEDIN BINDING PROTEIN 2; SYNTENIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; PROTEIN BINDING; SDCBP PROTEIN, HUMAN;

ANGIOGENESIS; BIOGENESIS; BREAST CARCINOMA; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL INVASION; CELL JUNCTION; CELL MIGRATION; CELL PROLIFERATION; CYTOPLASM; EPITHELIAL MESENCHYMAL TRANSITION; EXOSOME; GLIOBLASTOMA; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; METASTASIS; NERVE MEMBRANE; NEUROMODULATION; NONHUMAN; OLIGODENDROGLIA; PDZ DOMAIN; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SMALL CELL LUNG CANCER; SYNAPTOGENESIS; TRANSITIONAL CELL CARCINOMA; UBIQUITINATION; UVEA MELANOMA; ANIMAL; CELL MOTION; METABOLISM; NEOPLASM; PHYSIOLOGY;

ANIMALS; CELL ADHESION; CELL MOVEMENT; HUMANS; NEOPLASMS; PROTEIN BINDING; SYNTENINS;

EID: 84949105678     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25136     Document Type: Review

References (52)

1. Aissaoui H, Prevost C, Boucharaba A, Sanhadji K, Bordet JC, Negrier C, Boukerche H. 2015. MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, metastasis in melanoma cells. J Biol Chem 290:3333-3348.
2. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F, Coomans C, Vermeiren E, Zimmermann P, David G. 2012. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 14:677-685.
3. Beekman Jm, Coffer PJ. 2008. The ins and outs of syntenin, a multifunctional intracellular adaptor protein. J Cell Sci 121:1349-1355.
4. Beekman JM, Verhagen LP, Geijsen N, Coffer PJ. 2009. Regulation of myelopoiesis through syntenin-mediated modulation of IL-5 receptor output. Blood 114:3917-3927.
5. Boukerche H, Su ZZ, Emdad L, Baril P, Balme B, Thomas L, Randolph A, Valerie K, Sarkar D, Fisher PB. 2005. MDA-9/syntenin: A positive regulator of melanoma metastasis. Cancer Res 65:10901-10911.
6. Boukerche H, Su ZZ, Emdad L, Sarkar D, Fisher PB. 2007. MDA-9/syntenin regulates phenotype in human melanoma cells by activating nuclear factor-kB. Cancer Res 67:1812-1822.
7. Boukerche H, Su ZZ, Preot C, Sarkar D, Fisher PB. 2008. MDA-9/syntenin promotes in human melanoma cells by activating c-Src. Proc Natl Acad Sci USA 105:15914-15919.
8. Boukerche H, Aissaoui H, Prevost C, Hirbec H, Das SK, Su ZZ, Sarkar D, Fisher PB. 2010. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kB. Oncogene 29:3054-3066.
9. Chatterjee N, Stegmuller J, Schatzle P, Karram K, Koroll M, Werner HB, Nave KA, Trotter J. 2008. Interaction of syntenin-1 and NG2 proteoglycan in migratory oligodendrocyte precursor cells. J Biol Chem 283:8310-8317.
10. Chen F, Du Y, Zhang Z, Chen G, Zhang M, Shu HB, Zhai Z, Chen D. 2008. Syntenin negatively regulates TRAF6-mediated IL-1R/TLR4 signaling. Cell Signal 20:666-674.
11. Chiasserini D, van weering JR, Piersma SR, Pham TV, Malekzadeh A, Teunissen CE, de Wit H Jimenez. 2014. Proteomic analysis of cerebrospinal fluid extracellular vesicles: A comprehensive dataset. J Proteomics 106:191-204.
12. Cho W, Kim H, Lee JH, Hong SH, Choe J. 2013. Syntenin is exoressed in human follicular dendritic cells and involved in the activation of focal adhesion kinase. Immune Netw 13:199-204.
13. Dasgupta S, Menezes ME, Das SK, Emdad L, Janjic A, Bhatia S, Mukhopadhyay ND, Shao C, Sarkar D, Fisher PB. 2013. Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling. Clin Cancer Res 19:4621-4633.
14. Das SK, Bhutia SK, Sochi UK, Ahab B, Su ZZ, Boukerche H, Anwar T, Moen El, Chatterjee D, Pellecchia M, Sarkar D, Fisher PB. 2012. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma. Cancer Res 72:6217-6226.
15. Das SK, Bhutia SK, Azab B, Kegelman TP, Peachy L, Santhekadur PK, Dasgupta S, Dash R, Dent P, Grant S, Emdad L, Pellecchia M, Sarkar D, Fisher PB. 2013. MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma. Cancer Res 73:844-854.
16. Estrach S, Legg J, Watt FM. 2007. Syntenin mediates Delta1-induced cohesiveness of epidermal stem cells in culture. J Cell Sci 120:2944-2952.
17. Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, Blaydes JP, Brennan k, Brown NJ, Bryant HE, Bundred NJ, Burchell JM, Campbell AM, Carroll JS, Clarke RB, Coles CE, Cook GJ, Cox A, Curtin NJ, Dekker LV, Silva Idos S, Duffy SW, Easton DF, Eccles DM, Edwards DR, Edwards J, Evans D, Fenlon DF, Flanagan JM, Foster C, Gallagher WM, Garcia-Closas M, Gee JM, Gescher AJ, Goh V, Groves AM, Harvey AJ, Harvie M, Hennessy BT, Hiscox S, Holen I, Howell SJ, Howell A, Hubbard G, Hubert-Williams N, Hunter MS, Jasani B, Jones LJ, Key TJ, Kirwan CC, Kong A, Kunkler IH, Langdon SP, Leach MO, Mann DJ, Marshall JF, Martin L, Martin SG, Macdougall JE, Miles DW, Miller WR, Morris JR, Moss SM, Mullan P, Natrajan R, ÓConnor JP, ÓConner R, Palmieri C, Pharoah PD, Rakha EA, Reed E, Robinson SP, Sahai E, Saxton JM, Schmid P, Smalley MJ, Speirs V, Stein R, Stingl J, Streuli CH, Tutt AN, Velikova G, Walker RA, Watson CJ, Williams KJ, Young LS, Thompson AM. 2013. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res 15:R92.
18. Friand V, David G, Zimmermann P. 2015. Syntenin and syndecan in the biogenesis of exosomes. Bio Cell 10.1111/boc. 201500010.
19. Gangemi R, Mirisola V, Barisione G, Fabbi M, Brizzolara A, Lanza F, Mosci C, Salvi S, Gualco M, Trunini M, Angelini G, Boccardo S, Cilli M, Airoldi I, Queirolo P, Jager MJ, Daga A, Pfeffer U, Ferrini S. 2012. MDA-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. PLoS ONE 7:29989.
20. Geijsen N, Uings IJ, Pals C, Armstrong J, McKinnon M, Raaijmakers JA, Lammers JW, Koenderman L, Coffer PJ. 2001. Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein. Science 293:1136-1138.
21. Gimferrer I, Ibanez A, Farnos M, sarrias MR, Fenutria R, Rosello S, Zimmermann P, David G, Vives J, Serra-Pages C, Lozano F. 2005. The lymphocyte receptor CD6 interacts with syntenin-1, a scaffolding protein containing PDZ domains. J Immunol 175:1406-1414.
22. Gordon-Alonson M, Rocha-Perugini V, Alvarez S, Moreno-Gonzalo O, Ursa A, Lopez-Martin S, Izquierdo-Useros N, Martinez-Picado J, Munoz-Fernandez MA, Yanez-Mo M, Sanchez-Madrid F. 2012. The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry. Mol Biol Cell 23:2253-2263.
23. Grootjans JJ, Zimmermann P, Reekman G, Smets A, Degeest G, Durr J, David G. 1997. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci USA 94:13683-13688.
24. Hirbec H, Martin S, Henley JM. 2005. Syntenin is involved in the developmental regulation of neuronal membrane architecture. Mol Cell Neurosci 28:737-746.
25. Hwangbo C, Tae N, Lee S, Kim O, Park OK, Kim J, Kwon SH, Lee JH. 2015. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-medaited TGF-β type I receptor internalization. Oncogene 10.1038/onc.2015. 100.
26. Kahlert C, Kalluri R. 2013. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) 91:431-437.
27. Kegelman TP, Das SK, Hu B, Bacolod MD, Fuller CE, Menezes ME, Emadad L, Dasgupta S, Baldwin AS, Bruce JN, Dent P, Pellecchia M, Sarkar D, Fisher PB. 2014. MDA-9/syntenin is a key regulator of glioma pathogenesis. Neuro Oncol 16:50-61.
28. Kim WY, Jang JY, Jeon YK, Chung DH, Kim YG, Kim CW. 2014. Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1. Exp Mol Med 46:e90.
29. Koo TH, Lee JJ, Kim EM, Kim KW, Kim HD, Lee JH. 2002. Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines. Oncogene 21:4080-4088.
30. Lambaerts K, Van Dyck S, Mortier S, Ivarsson Y, Degeest G, Luyten A, Vermeriren E, Peers B, David G, Zimmermann P. 2012. Syntenin, a syndecan adaptor and an Arf6 phosphatidylinositol 4, 5-bisphosphate effector, is essential for epiboly and gastrulation cell movements in zebrafish. J Cell Sci 125:1129-1140.
31. Latysheva N, Muratov G, Rajesh S, Padgett M, Hotchin NA, Overduin M, Berditchevski F. 2006. Syntenin-1 is a new component of tetraspanin-enriched microdomains: Mechanisms and consequences of the interaction of syntenin-1 with CD63. Mol Cell Biol 26:7707-7718.
32. Lee H, Kim Y, Choi Y, Choi S, Hong E, Oh ES. 2011. Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1. Biochem Biophys Res Commun 409:148-153.
33. Lin JJ, Jiang H, Fisher PB. 1998. Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. Gene 207:105-110.
34. Lopez-Ramirez MA, Wu D, Pryce G, Simpson JE, Reijerkerk A, King-Robson J, Kay O, de Vries HE, Hirst MC, Sharrack B, Baker D, Male DK, Michael GJ, Romero IA. 2014. MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation. FASEB J 28:2551-2565.
35. McClelland AC, Sheffler-Collins SI, Kayser MS, Dalva MB. 2009. Ephrin-B1 and Ephrin-B2 mediate EphB-dependent presynaptic development via syntenin-1. Proc Natl Acad Sci USA 106:20487-20492.
36. Meerschaert K, Bruyneel E, De Wever O, Vanloo B, Boucherie C, Bracke M, Vandekerckhove J, Gettemans J. 2007. The tandem PDZ domains of syntenin promote cell invasion. Exp Cell Res 313:1790-1804.
37. Ohno K, Koroll M, El Far O, Scholze P, Gomeza J, Betz H. 2004. The neuronal glycine transporter 2 interacts with the PDZ domain protein syntenin-1. Mol Cell Neurosci 26:518-529.
38. Okumura F, Yoshida K, Liang F, Hatakeyama S. 2011. MDA-9/syntenin interacts with ubiquitin via a novel ubiquitin-binding motif. Mol Cell Biochem 352:163-172.
39. Qian XL, Li YQ, Yu B, Gu F, Liu FF, Li WD, Zhang XM, Fu L. 2013. Syndecan binding protein (SDCBP) is overexpressed in estrogen receptor negative breast cancers, and is a potential promoter for tumor. PLoS ONE 8:e60046.
40. Rajesh S, Bago R, Odintsova E, Muratov G, Sridhar P, Rajesh S, Overduin M, Berditchevski F. 2011. Binding to syntenin-1 protein defines a new mode of ubiquitin-based interactions regulated by phosphorylation. J Biol Chem 286:39606-39614.
41. Sala-Valdes M, Gordon-Alonson M, Tejera E, Ibanez A, Cabrero JR, Ursa A, Mittelbrunn M, Lozano F, Sanchez-Madrid F, Yanez-Mo M. 2012. Association of syntenin-1 with M-RIP polarizes Rac-1 activation during chemotaxis and immune interactions. J Cell Sci 125:1235-1246.
42. Shteingauz A, Ilan N, Vlodavsky I. 2014. Processing of heparanase I smediated by syndecan-1 cytoplasmic domain and onvolves syntenin and α-actinin. Cell Mol Life Sci 71:4457-4470.
43. Stier S, Totzke G, Grunewald E, Neuhaus T, Fronhoffs S, Sachinidis A, Vetter H, Schulze-Osthoff K, Ko Y. 2000. Identification of syntenin and other TNF-inducible genes in human umbilical arterial endothelial cells by suppression subtractive hybridization. FEBS Lett 467:299-304.
44. Tamura K, Ikutani M, Yoshida T, Tanaka-Hayashi A, Yanagibashi T, Inoue R, Nagai Y, Adachi Y, Miyawaki T, Takatsu K, Mori H. 2015. Increased production of intestinal immunoglobulins in syntenin-1-deficient mice. Immunobiology 220:597-604.
45. Thery C, Boussac M, Veron p, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S. 2001. Proteomic analysis of dendritic cell-derived exosomes: A secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 166:7309-7318.
46. Tomlinson PR, Zheng Y, Fischer R, Heidasch R, Gardiner C, Evetts S, Hu M, Wade-Martins R, Turner MR, Morris J, Talbot K, Kessler BM, Tofaris GK. 2015. Identification of distinct circulating exosomes in parkinsońs disease. Ann Clin Transl Neurol 2:353-361.
47. Tudor C, te Riet J, Eich C, Harkes R, Smisdom N, Bouhuijzen Wenger J, Ameloot M, Holt M, Kanger JS, Figdor CG, Cambi A, Subramaniam V. 2014. Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeleton. J Biol Chem 289:13445-13460.
48. Wawrzyniak AM, Vermeriren E, Zimmermann P, Ivarsson Y. 2012. Extensions of PSD-95/discs large/ZO-1 (PDZ) domains influence lipid binding and membrane targeting of syntenin-1. FEBS Lett 586:1445-1451.
49. Xiao D, Ohlendorf J, Chen Y, Taylor DD, Rai SN, Waigel S, Zacharias W, Hao H, McMasters Km. 2012. Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLos ONE 7:e46874.
50. Yang Y, Hong Q, Shi P, Liu Z, Luo J, Shao Z. 2013. Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival. Breast Cancer Res 15:R50.
51. Zhong D, Ran JH, Tang WY, Zhang XD, Tan Y, Chen GJ, Li XS, Yan Y. 2012. MDA-9/syntenin promotes human brain glioma migration through focal adhesion kinase (FAK)-JNK and FAK-AKT signaling. Asian Pac J Cancer Prev 13:2897-2901.
52. Zimmermann P, Tomatis D, Rosas M, Grootjans J, Leenaerts I, Degeest G, Reekmans G, Coomans C, David G. 2001. Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments. Mol Biol Cell 12:339-350.